We also consider that the patient with DNAJC12 deficiency should receive BH4 treatment which can be effective for correcting the biochemical abnormalities and long‐term prognosis. This evidence concerns the gene DNAJC12 and hyperinsulinemic hypoglycemia, familial, 4.